Browse Category

Stock Market News 15 January 2026

Coinbase stock in focus after CEO Armstrong pulls backing for Senate crypto bill draft

Coinbase stock in focus after CEO Armstrong pulls backing for Senate crypto bill draft

Coinbase CEO Brian Armstrong withdrew support for the Senate’s latest crypto market-structure bill, citing “too many issues” ahead of a key committee markup Thursday. The draft would restrict stablecoin interest payments and expand SEC oversight, drawing mixed industry reactions. Lawmakers remain divided over stablecoin rules and regulatory authority as the Senate Banking Committee prepares to meet.
Critical Metals (CRML) jumps after Greenland drill assays — what to watch next

Critical Metals (CRML) jumps after Greenland drill assays — what to watch next

Critical Metals shares surged 33% to $17.93 in after-hours trading Wednesday after releasing new drill assay results from its Tanbreez rare earth project in Greenland. Around 60 million shares traded hands amid heavy volatility. The company reported steady grades and significant heavy rare earth content, with more assay results pending. President Trump delayed tariffs on rare earths and lithium, urging officials to secure supplies abroad.
15 January 2026
Circle stock (CRCL) rises after-hours as stablecoin regulation battle returns to Washington

Circle stock (CRCL) rises after-hours as stablecoin regulation battle returns to Washington

Circle Internet Group shares rose 1.7% in after-hours trading Wednesday, closing at $84.80. The move followed a Senate draft bill proposing new rules for stablecoins and crypto markets, including limits on interest payments. Circle reported $9.6 trillion in USDC onchain volume for Q3 2025. Polygon Labs announced a $250 million deal to acquire Coinme and Sequence to expand stablecoin payments.
AbbVie stock in focus after hours as it eyes obesity market — what to watch next

AbbVie stock in focus after hours as it eyes obesity market — what to watch next

AbbVie shares rose about 0.5% to $221.89 in after-hours trading Wednesday after executives outlined plans to expand into obesity treatments. The company is betting on GUBamy, a drug licensed from Denmark’s Gubra, and highlighted its focus on amylin-based therapies. Investors are watching for pricing pressure from Washington ahead of AbbVie’s Feb. 4 earnings report.
Lockheed Martin stock jumps after hypersonic missile engine test with GE, Stinger-replacement flight milestone

Lockheed Martin stock jumps after hypersonic missile engine test with GE, Stinger-replacement flight milestone

Lockheed Martin shares rose 2.6% in after-hours trading Wednesday after it and GE Aerospace announced successful tests of a new ramjet engine for hypersonic missiles. Citi raised its price target for Lockheed to $592 ahead of the Jan. 29 earnings call. Northrop Grumman, RTX, and General Dynamics also gained, while GE Aerospace slipped 2.5%.
D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave Quantum shares rose 4.7% to $30.15 in after-hours trading Wednesday after Honeywell said its Quantinuum unit plans to file confidential IPO documents with the SEC. Other U.S. quantum stocks, including IonQ and Rigetti, also gained. D-Wave’s $550 million acquisition of Quantum Circuits is expected to close by late January, pending approvals. Traders are watching for D-Wave’s upcoming user conference and the Quantum Circuits deal.
Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher shares closed up 2.4% at $621.83 Wednesday and held steady after hours, following news of new U.S. drug manufacturing contracts. CEO Marc Casper cited a focus on reshoring production from Europe and Asia. A recent SEC filing detailed leadership changes effective in March, including COO Michel Lagarde’s exit. The company also announced a partnership with Nvidia to expand AI in lab automation.

Stock Market Today

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
Cadence Bank shares have been delisted following Huntington Bancshares’ takeover, with each Cadence share converted into 2.475 Huntington shares. Huntington closed Friday at $19.27 and named Senthil Kumar as chief risk officer ahead of new regulatory requirements. The merger leaves Cadence as a brand under Huntington, with customer account conversions planned for mid-2026. Huntington executives will address investors at a UBS conference on Tuesday.
NIO stock jumps on profit alert, with Monday’s open in focus

NIO stock jumps on profit alert, with Monday’s open in focus

7 February 2026
NIO shares jumped 7.23% to $5.04 Friday after the company forecast a swing to adjusted operating profit of up to 1.2 billion yuan for the fourth quarter. Trading volume reached 90.8 million shares, far above average. Nio’s deliveries rose 72% to 124,807 vehicles in the quarter. The company said results are preliminary and unaudited, with final figures due in March.
Snap stock price bounces to $5.22 after upgrades — what traders watch next week

Snap stock price bounces to $5.22 after upgrades — what traders watch next week

7 February 2026
Snap Inc. shares closed up 2% at $5.22 Friday after a volatile week, with 94 million shares traded. The company forecast Q1 revenue below analyst expectations, despite a fourth-quarter beat and a 28% rise in active advertisers. Daily active users fell by 3 million to 474 million. Analysts remain divided, with some upgrading and others trimming price targets.
Bradesco stock drops on 2026 guidance — what BBDC4 investors watch next week

Bradesco stock drops on 2026 guidance — what BBDC4 investors watch next week

7 February 2026
Bradesco’s preferred shares fell 2.55% to 20.61 reais Friday after the bank issued 2026 guidance pointing to slower growth in some areas. Fourth-quarter recurring net income rose 20.6% to 6.5 billion reais, with 2025 ROAE at 15.2%. The Ibovespa closed up 0.45%. Bradesco ADRs ended down 0.5% at $3.98 in New York.
Go toTop